Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 19, 2023

SELL
$160.94 - $186.23 $5,954 - $6,890
-37 Reduced 2.53%
1,428 $245,000
Q1 2023

May 04, 2023

BUY
$145.48 - $175.02 $213,128 - $256,404
1,465 New
1,465 $243,000
Q2 2019

Aug 06, 2019

SELL
$97.98 - $114.28 $17,244 - $20,113
-176 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$81.56 - $100.67 $8,890 - $10,973
109 Added 162.69%
176 $18,000
Q3 2018

Nov 14, 2018

SELL
$83.5 - $93.23 $2,839 - $3,169
-34 Reduced 33.66%
67 $6,000
Q1 2018

Apr 20, 2018

BUY
$71.51 - $84.69 $7,222 - $8,553
101 New
101 $8,000
Q4 2017

Feb 22, 2018

SELL
$63.24 - $72.8 $2,529 - $2,912
-40 Closed
0 $0
Q3 2017

Oct 27, 2017

BUY
$59.73 - $65.4 $2,389 - $2,616
40
40 $3,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Cable Hill Partners, LLC Portfolio

Follow Cable Hill Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cable Hill Partners, LLC with notifications on news.